A company that is ready for an FDA inspection is less likely to receive 483 observations than a disorganized one. This 60-minute webinar covers how to prepare for and host an FDA inspection, and what to do if a Form 483 or warning letter follows.
You'll look at the types of FDA inspections, assigning people to specific inspection tasks, setting up front room and back room facilities, the value of mock audits, and how staff should behave, including what not to sign.
The session also explains the FDA's rights during an inspection, the documents you are not required to show, and why the timing and content of your 483 response matter so much.
WHY SHOULD YOU ATTEND?
The FDA will inspect you, so the question is whether you're ready. Preparation lowers the chance of 483s, and knowing how to respond to a 483 reduces the chance it turns into a warning letter.
The webinar suits medical device companies marketing in the U.S. and their executives, regulatory, QA, quality and compliance managers, auditors, quality engineers, CAPA specialists, management representatives, consultants and anyone who may deal directly with FDA officials.
AREA COVERED
- Types of FDA inspections
- Preparing personnel and assigning inspection tasks
- Facility requirements: front room and back room
- Internal and mock audits
- Procedures during the audit: what to do and what not to do
- Behavior during the inspection, including what not to sign
- FDA rights and documents you don't have to show
- Responding to 483s and warning letters
LEARNING OBJECTIVES
- Prepare personnel and assign roles for an FDA inspection
- Set up facilities, including front and back rooms, to support the inspection
- Use internal and mock audits to get ready
- Follow the right procedures and conduct during the inspection
- Explain FDA's rights and which documents you need not provide
- Respond to 483 observations and warning letters effectively and on time
WHO WILL BENEFIT?
This webinar will provide valuable assistance to all companies that market in the U.S., since they are by definition subject to FDA regulation, in the Medical Device, fields. The employees who will benefit include:
- Executive/senior management
- Regulatory management
- QA management
- Any person who may have direct interaction with FDA officials
- Consultants
- Quality system auditors
- Quality Engineers
- Compliance Specialists
- Compliance Leaders
- CAPA Specialists
- Management Representatives
- Compliance Managers and Directors
- Quality Managers and Directors
- Consultants and Contractors
The FDA will inspect you, so the question is whether you're ready. Preparation lowers the chance of 483s, and knowing how to respond to a 483 reduces the chance it turns into a warning letter.
The webinar suits medical device companies marketing in the U.S. and their executives, regulatory, QA, quality and compliance managers, auditors, quality engineers, CAPA specialists, management representatives, consultants and anyone who may deal directly with FDA officials.
- Types of FDA inspections
- Preparing personnel and assigning inspection tasks
- Facility requirements: front room and back room
- Internal and mock audits
- Procedures during the audit: what to do and what not to do
- Behavior during the inspection, including what not to sign
- FDA rights and documents you don't have to show
- Responding to 483s and warning letters
- Prepare personnel and assign roles for an FDA inspection
- Set up facilities, including front and back rooms, to support the inspection
- Use internal and mock audits to get ready
- Follow the right procedures and conduct during the inspection
- Explain FDA's rights and which documents you need not provide
- Respond to 483 observations and warning letters effectively and on time
This webinar will provide valuable assistance to all companies that market in the U.S., since they are by definition subject to FDA regulation, in the Medical Device, fields. The employees who will benefit include:
- Executive/senior management
- Regulatory management
- QA management
- Any person who may have direct interaction with FDA officials
- Consultants
- Quality system auditors
- Quality Engineers
- Compliance Specialists
- Compliance Leaders
- CAPA Specialists
- Management Representatives
- Compliance Managers and Directors
- Quality Managers and Directors
- Consultants and Contractors
Speaker Profile
Edwin Waldbusser
Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Upcoming Webinars
NEW Nacha Rule - Third-Party Sender (TPS) Roles and Respons…
Paying and Receiving Payments for Referrals: You Can Go to …
FDA Technology Modernization Action Plan (TMAP) and Impact …
Human Factors Usability Studies Following ISO 62366 and FDA…
Validation Statistics for Non-Statisticians
Construction Lending And Real Credit Administration: Evalua…
Thriving in a Hybrid Workplace: Keys to Leadership and Team…
Excel Power Skills: Master Functions, Formulas, and Macros …
Discover how Emotional Intelligence turns AI from a technic…
Batch Record Review and Product Release
Tattoos, hijabs, piercings, and pink hair: The challenges …
Handbook Overhaul 2026: Compliance, OBBB Act & Beyond
Copilot and HR: An Introduction for HR Professionals
Female to Female Hostility @Workplace: All you Need to Know
ChatGPT for HR - Build HR Policy Framework and Strategy
Excel Spreadsheets; Develop and Validate for 21 CFR Part 11…
Major cGMP Issues: FDA Concerns in 2026
The Perfect Storm Coming to Healthcare: Value Based Care Me…
Fostering a Culture of Respect: Eliminating Gossip, Rumour…
Language is Code - Intro to AI - Generative AI - ChatGPT an…
Excel + AI: The Smart User's Guide to Faster, Easier Work w…
The Importance of the first 5 seconds when presenting
Managing Difficult Employee Conversations
ChatGPT and Project Management: Leveraging AI for Project M…
I-9 Audits: Strengthening Your Immigration Compliance Strat…
Pivot tables beginner to advanced + 20 advanced Pivot table…
Emotional Intelligence: Mastering the Emotions of Great Lea…
2026 Nacha Rules Changes (Part 1): Fraud Monitoring & Ops B…
Accounting For Non Accountants : Debit, Credits And Financi…
Medical Device Cybersecurity Following FDA’s 2026 Premarket…
Performance of Root Cause Analysis, CAPA, and Effectiveness…
Human Error Reduction Techniques for Floor Supervisors